Stay updated on RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no study details, contacts, locations, or outcomes were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T04:32:37.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a dedicated Locations section listing Beijing Municipality and Liaoning as study sites, replacing the previous location groupings.
    Difference
    0.2%
    Check dated 2025-12-23T12:41:14.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Last known status on the study record now shows 'Unknown status' with attribution to RemeGen Co., Ltd. and a verification timestamp (2023-11).
    Difference
    0.2%
    Check dated 2025-12-01T19:56:42.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2. There are no changes to study details, eligibility criteria, or trial content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T17:00:54.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Removed the government funding and operating status notice from the study page, a disclaimer that previously warned information may not be up to date due to appropriations.
    Difference
    0.2%
    Check dated 2025-11-17T14:59:08.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    No substantive changes to study details; only minor formatting/UI adjustments observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:26:39.000Z thumbnail image

Stay in the know with updates to RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page.